FB2026_02 , released June 18, 2026
Human Disease Model Report: hypervalinemia and hyperleucine-isoleucinemia
Open Close
General Information
Name
hypervalinemia and hyperleucine-isoleucinemia
FlyBase ID
FBhh0001601
Disease Ontology Term
Parent Disease
Overview

This report describes hypervalinemia and hyperleucine-isoleucinemia, an inheritated amino acid metabolic disorder. The human gene implicated is BCAT2, which encodes branched chain amino acid transaminase 2, functional comment. There is one high-scoring fly ortholog, Dmel\Bcat, for which multiple genetic reagents, including a loss of function allele, classical alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated.

Wild-type Hsap\BCAT2 has been introduced into flies, but has not been used to model disease; partial heterologous rescue (functional complementation) of the loss of function Dmel\Bcat semilethal phenotype has been demonstrated.

A Dmel\Bcat allele that produces a truncated protein product results in a 4% adult survival rate; transgenic expression of Hsap\BCAT2 results in a 60% survival rate. Treatment with a diet in which the concetration of branched-chain amino acids (Leu, Ile, Val) was reduced by 50% resulted in a 34% survival rate, while a dietary reduction in one or two BCAAs did not affect the survival rate.

[updated Sept. 2024 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: hypervalinemia and hyperleucine-isoleucinemia
OMIM report

[HYPERVALINEMIA AND HYPERLEUCINE-ISOLEUCINEMIA; HVLI](https://omim.org/entry/618850)

Human gene(s) implicated

[BRANCHED-CHAIN AMINOTRANSFERASE 2; BCAT2](https://omim.org/entry/113530)

Symptoms and phenotype

Hypervalinemia and hyperleucine-isoleucinemia is associated with developmental delay, intellectual disability, seizures, and movement defects (Knerr, et al., 2019, pubmed:31177572).

Hypervalinemia and hyperleucine-isoleucinemia (HVLI) is a branched-chain amino acid metabolic disorder characterized by highly elevated plasma valine and leucine concentrations. [from MIM:618850; 2024.09.05]

Genetics

Hypervalinemia and hyperleucine-isoleucinemia (HVLI) is caused by compound heterozygous mutation in the BCAT2 gene on chromosome 19q13. [from MIM:618850; 2024.09.09]

Cellular phenotype and pathology
Molecular information

The BCAT2 gene encodes the mitochondrial isoform of the branched-chain amino acid (BCAA) aminotransferase (BCAT), which catalyzes the transamination of the branched-chain amino acids (leucine, isoleucine, and valine) to their respective alpha-keto acids in the first step of BCAA catabolism (summary by Wang et al., 2015, pubmed:25653144). [from MIM:113530; 2024.09.09]

External links
Disease synonyms
BCAA transaminase deficiency
branched chain amino acid transaminase deficiency
branched-chain aminotransferase 2 deficiency
branched-chain aminotransferase deficiency
HVLI
hypervalinemia or hyperleucine-isoleucinemia
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Two to one (2 human to 1 Drosophila); BCAT2 has one high-scoring Drosophila ortholog, Bcat.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Branched chain amino acid transaminase (Bcat) encodes an enzyme that catalyzes the transamination of branched chain amino acids (BCAAs) L-valine, L-leucine and L-isoleucine into their corresponding branched chain alpha-ketoacids (BCKAs) in the first step of BCAA catabolism. [Date last reviewed: 2025-10-30]
    Cellular component (GO)
    Gene Groups / Pathways
    Comments on ortholog(s)

    High-scoring ortholog of human BCAT1 and BCAT2 (1 Drosophila to 2 human).

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (1 groups)
      protein-protein
      Interacting group
      Assay
      References
      experimental knowledge based
      Alleles Reported to Model Human Disease (Disease Ontology) (1 alleles)
      Models Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 0 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      amorphic allele - molecular evidence
      CRISPR/Cas9
      References (5)